HABA Laboratories,Inc. (4925.T)
JPY 1621.0
(-1.1%)
JPY 1621.0
(-1.1%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -587.92 Million | 55.95 Million | 1.71 Billion | 534.71 Million | 675.5 Million | 1.92 Billion |
| Net Income | -2.11 Billion | -548.66 Million | -266.95 Million | 283.92 Million | 1.92 Billion | 3.07 Billion |
| Depreciation & Amortization | 519.27 Million | 559.65 Million | 708.07 Million | 669.21 Million | 630.2 Million | 616.88 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -688.02 Million | -85.98 Million | 1.05 Billion | 10.63 Million | -712.73 Million | -978.38 Million |
| Other non-cash items | 3.54 Billion | 130.94 Million | 220.77 Million | -429.06 Million | -1.16 Billion | -790.13 Million |
| Investing Cash Flow | -441.78 Million | -214.4 Million | -216.49 Million | -925.07 Million | -920.25 Million | -471.23 Million |
| Investments in PPE | -434.12 Million | -288.65 Million | -187.5 Million | -881.65 Million | -909.97 Million | -472.83 Million |
| Acquisitions | 18.78 Million | 30.47 Million | 8.43 Million | 69.65 Million | 27.94 Million | 1.23 Million |
| Investment purchases | - | - | - | - | - | 169.23 Million |
| Sales/Maturities of investments | - | - | - | - | - | 510 Thousand |
| Other Investing Activities | -26.56 Million | 43.77 Million | -37.42 Million | -113.07 Million | -38.23 Million | -169.38 Million |
| Financing Cash Flow | 171.06 Million | -676.32 Million | -1.51 Billion | 825.38 Million | -448.74 Million | -571.6 Million |
| Debt repayment | -322.23 Million | -825.04 Million | -961.79 Million | -833.13 Million | -784.81 Million | -753.06 Million |
| Dividends payments | -151.17 Million | -151.28 Million | -151.12 Million | -151.35 Million | -157.27 Million | -118.04 Million |
| Common Stock Repurchased | - | - | -64 Thousand | -122 Thousand | -1.15 Billion | -504 Thousand |
| Common Stock Issuance | - | - | -400 Million | 1.81 Billion | - | 300 Million |
| Other Financing Activities | -1000.00 | 300 Million | -1000.00 | -2000.00 | 1.65 Billion | -1000.00 |
| Accounts receivables | -284.75 Million | 142.54 Million | 93.48 Million | 224.56 Million | 547.24 Million | -100.46 Million |
| Accounts payables | -172.67 Million | 139.52 Million | 25.9 Million | -164.12 Million | -19.95 Million | 146.74 Million |
| Inventory | -344.98 Million | -216.91 Million | 883.1 Million | 223.93 Million | -1.35 Billion | -608.92 Million |
| Other working capital | 114.38 Million | -151.13 Million | 50.06 Million | -273.74 Million | 119.77 Million | -415.74 Million |
| Cash at beginning of period | 4.81 Billion | 5.65 Billion | 5.66 Billion | 5.22 Billion | 5.92 Billion | 5.04 Billion |
| Cash at end of period | 3.95 Billion | 4.81 Billion | 5.65 Billion | 5.66 Billion | 5.22 Billion | 5.92 Billion |
| Capital Expenditure | -434.12 Million | -288.65 Million | -187.5 Million | -881.65 Million | -909.97 Million | -472.83 Million |
| Effect of forex changes on cash | - | 1.32 Million | 2.68 Million | 258 Thousand | -610 Thousand | -1.39 Million |
| Net cash flow / Change in cash | -858.64 Million | -833.44 Million | -12.33 Million | 435.27 Million | -694.1 Million | 877.57 Million |
| Free Cash Flow | -1.02 Billion | -232.69 Million | 1.52 Billion | -346.94 Million | -234.46 Million | 1.44 Billion |
| Breakdown | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -22 Million | -1.2 Billion | -2.11 Billion | -567 Million | -130 Million | -215 Million |
| Depreciation & Amortization | - | - | 519.27 Million | 124.35 Million | 128.84 Million | 119.19 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | - | -688.02 Million | - | - | - |
| Other non-cash items | 22 Million | 1.2 Billion | 3.54 Billion | 567 Million | 130 Million | 215 Million |
| Investing Cash Flow | - | - | -441.78 Million | - | - | - |
| Investments in PPE | - | - | -434.12 Million | - | - | - |
| Acquisitions | - | - | 18.78 Million | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | -26.56 Million | - | - | - |
| Financing Cash Flow | - | - | 171.06 Million | - | - | - |
| Debt repayment | - | - | -322.23 Million | - | - | - |
| Dividends payments | - | - | -151.17 Million | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | - | - | -1000.00 | - | - | - |
| Accounts receivables | - | - | -284.75 Million | - | - | - |
| Accounts payables | - | - | -172.67 Million | - | - | - |
| Inventory | - | - | -344.98 Million | - | - | - |
| Other working capital | - | - | 114.38 Million | - | - | - |
| Cash at beginning of period | - | - | 4.81 Billion | 3.63 Billion | 3.75 Billion | 4.81 Billion |
| Cash at end of period | - | - | 3.95 Billion | 3.77 Billion | 3.63 Billion | 3.75 Billion |
| Capital Expenditure | - | - | -434.12 Million | - | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | - | - | -858.64 Million | 134.85 Million | -120.86 Million | -1.06 Billion |
| Free Cash Flow | - | - | -1.02 Billion | 248.7 Million | 257.69 Million | 238.38 Million |
RZI
018250
MIR
SARKY
4927
RYAHF